Testing effectiveness (Phase 2)Active Not RecruitingNCT04940546
What this trial is testing
Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients
Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 36